Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 6 studies | 42% ± 11% |
Insufficient scRNA-seq data for expression of TM4SF20 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 69% | 1503.33 | 664 / 966 | 74% | 20.20 | 390 / 527 |
stomach | 35% | 3.01 | 126 / 359 | 74% | 20.69 | 213 / 286 |
pancreas | 47% | 3.06 | 153 / 328 | 43% | 18.99 | 76 / 178 |
spleen | 80% | 7.22 | 193 / 241 | 0% | 0 | 0 / 0 |
esophagus | 25% | 4.11 | 368 / 1445 | 44% | 26.51 | 80 / 183 |
brain | 61% | 7.35 | 1620 / 2642 | 1% | 0.01 | 4 / 705 |
liver | 35% | 2.27 | 80 / 226 | 25% | 12.35 | 101 / 406 |
adrenal gland | 58% | 4.53 | 150 / 258 | 0% | 0 | 0 / 230 |
adipose | 55% | 6.21 | 658 / 1204 | 0% | 0 | 0 / 0 |
kidney | 52% | 3.91 | 46 / 89 | 1% | 0.04 | 9 / 901 |
bladder | 29% | 1.81 | 6 / 21 | 20% | 2.99 | 99 / 504 |
lung | 30% | 2.31 | 175 / 578 | 13% | 7.10 | 151 / 1155 |
thymus | 43% | 3.32 | 279 / 653 | 0% | 0 | 0 / 605 |
breast | 42% | 4.23 | 191 / 459 | 0% | 0.00 | 1 / 1118 |
prostate | 39% | 2.57 | 96 / 245 | 2% | 0.10 | 10 / 502 |
skin | 36% | 25.08 | 656 / 1809 | 1% | 0.06 | 5 / 472 |
uterus | 35% | 4.51 | 59 / 170 | 3% | 1.60 | 12 / 459 |
peripheral blood | 35% | 3.32 | 325 / 929 | 0% | 0 | 0 / 0 |
ovary | 29% | 2.32 | 53 / 180 | 0% | 0 | 0 / 430 |
blood vessel | 18% | 1.21 | 238 / 1335 | 0% | 0 | 0 / 0 |
heart | 12% | 0.70 | 104 / 861 | 0% | 0 | 0 / 0 |
muscle | 10% | 0.56 | 81 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045861 | Biological process | negative regulation of proteolysis |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005925 | Cellular component | focal adhesion |
GO_0005515 | Molecular function | protein binding |
Gene name | TM4SF20 |
Protein name | Transmembrane 4 L6 family member 20 Transmembrane 4 L six family member 20 |
Synonyms | UNQ518/PRO994 |
Description | FUNCTION: Polytopic transmembrane protein that inhibits regulated intramembrane proteolysis (RIP) of CREB3L1, inhibiting its activation and the induction of collagen synthesis . In response to ceramide, which alters TM4SF20 membrane topology, stimulates RIP activation of CREB3L1 . Ceramide reverses the direction through which transmembrane helices are translocated into the endoplasmic reticulum membrane during translation of TM4SF20, this mechanism is called 'regulated alternative translocation' (RAT) and regulates the function of the transmembrane protein . . |
Accessions | Q53R12 C9JES4 ENST00000449706.1 ENST00000304568.4 |